These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34673651)

  • 1. Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Goldberg A; Garcia-Arroyo F; Sasai F; Rodriguez-Iturbe B; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2021; 52(10-11):837-844. PubMed ID: 34673651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urate reduction and renal preservation: what is the evidence?
    Macías N; Goicoechea M; de Vinuesa MS; Verdalles U; Luño J
    Curr Rheumatol Rep; 2013 Dec; 15(12):386. PubMed ID: 24203097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.
    Sato Y; Feig DI; Stack AG; Kang DH; Lanaspa MA; Ejaz AA; Sánchez-Lozada LG; Kuwabara M; Borghi C; Johnson RJ
    Nat Rev Nephrol; 2019 Dec; 15(12):767-775. PubMed ID: 31296965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hyperuricemia in Chronic Kidney Disease.
    Ramirez-Sandoval JC; Madero M
    Contrib Nephrol; 2018; 192():135-146. PubMed ID: 29393124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid and chronic kidney disease: which is chasing which?
    Johnson RJ; Nakagawa T; Jalal D; Sánchez-Lozada LG; Kang DH; Ritz E
    Nephrol Dial Transplant; 2013 Sep; 28(9):2221-8. PubMed ID: 23543594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problem of cardio-renal diseases in patients with gout.
    Ferri C
    Curr Med Res Opin; 2017 Nov; 33(sup3):9-13. PubMed ID: 28952391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.
    Jalal DI
    Curr Med Res Opin; 2016 Nov; 32(11):1863-1869. PubMed ID: 27470664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
    Petreski T; Ekart R; Hojs R; Bevc S
    Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia and chronic kidney disease: to treat or not to treat.
    Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Effects of Hyperuricemia.
    Méndez Landa CE
    Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricaemia and Chronic Kidney Disease].
    Garofalo C; De Stefano T; Vita C; Vinci G; Balia F; Nettuno F; Scarpati L; Sguazzo A; Sagliocchi A; Pacilio M; Minutolo R; De Nicola L; Borrelli S
    G Ital Nefrol; 2018 Feb; 35(1):. PubMed ID: 29390240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
    Gul A; Zager P
    Curr Diab Rep; 2018 Mar; 18(4):18. PubMed ID: 29497863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
    Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid and the risk of cardiovascular and renal disease.
    Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
    J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in CKD: has the jury come to the verdict?
    Bonino B; Leoncini G; Russo E; Pontremoli R; Viazzi F
    J Nephrol; 2020 Aug; 33(4):715-724. PubMed ID: 31933161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review.
    Hu AM; Brown JN
    Clin Rheumatol; 2020 Nov; 39(11):3287-3294. PubMed ID: 32418037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.